Loading…
KBMO Diagnostics provides advanced diagnostic tests for healthcare providers, delivering actionable, easy-to-understand individual data to guide patient treatment. Their test portfolio includes the Food Inflammation Test (FIT), Gut Barrier Panel (GBP), Organic Acids (MIP), Glyphosate Exposure Test, and Cardiovascular Inflammation Test (CIT), among others. They support practitioners with a provider portal, patient kits, collection instructions, and educational resources, and partner with Fullscript for prescribing and managing supplements.
AI named KBMO Diagnostics from December 2025 to February 2026.